SHR-1210 also reduces the proportion of oxygen-depleted cells in tumors, promotes increased oxygenation, and directly improves radiosensitivity, promotes apoptosis, reduces tumor neovascularization, and then effectively down-regulates serum SCC and VEGF levels in cancer patients [25]. Here, VEGFA is linked to neoplasm.